« AnteriorContinuar »
NATIONAL CANCER ACT OF 1974
WEDNESDAY, JANUARY 30, 1974
Washington, D.C. The subcommittee met, pursuant to notice, at 10:13 a.m., in room 4232, Dirksen Senate Office Building, Hon. Edward M. Kennedy, chairman of the subcommittee, presiding.
Present: Senators Kennedy, Pell, Nelson, Javits, Schweiker, Dominick, Beall, and Taft.
Staff members present: LeRoy G. Goldman, professional staff member, and Jay B. Cutler, minority counsel.
Senator KENNEDY. The subcommittee will come to order.
The national cancer program has been in progress for 2 years. Much has been accomplished. But much more remains to be accomplished.
Some major advances have been recorded in 1973. The first artificial gene has been created with potential for life function. A tentative but hopeful approach to immunotherapy for acute leukemia patients has been developed. The first evidence that some form of advanced non-Hodgkin's lymphoma can be controlled for long periods.
Survival of cancer patients overall has almost doubled since the early 1930's. Today, one out of three persons with cancer will be alive 5 years after treatment.
However, as important as these advances have been, an estimated 650,000 new cases will be diagnosed and more than a third of a million Americans will die in 1974.
Unless more progress can be made, cancer will continue to strike one in four of all Americans.
Before the Cancer Act became law, there were only three comprehensive cancer centers in the Nation—two in New York and one in Texas. The act permitted the creation of 15 new centers, of which nine have now been funded, and the other six will be funded by June. But this is not enough.
The Nation needs between 30 and 35 comprehensive centers. No American should be denied cancer treatment simply because of where he may live.
Two of the principal killers are lung cancer and breast cancer. The annual toll for lung cancer is about 75,000 and breast cancer takes the life of one American woman every 15 minutes.
I am, therefore, gratified that the cancer program is making a major effort in both of these areas.
Essentially, I believe this program is working well.
The 3-year extension which Senator Javits and I introduced does substantially increase the authorization levels for the program. It also removes the legislative limitation on the number of comprehensive centers which may be funded.
[The text of S. 2893 follows:]
IN THE SENATE OF THE UNITED STATES
JANUARY 24, 1974
HATHAWAY, Mr. Hughes, Mr. MONDALE, Mr. Pell, Mr. RANDOLPII, Mr.
To amend the Public Health Service Act to improve the national
cancer program and to authorize appropriations for such pro
gram for the next three fiscal years. 1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 3 That this Act may be cited as the "National Cancer Act
4 Amendments of 1974".
SEC. 2. Section 402 (b) of the Public Health Service
6 Act is amended
(1) by striking out “in amounts not to exceed $35,000" in paragraph (1) and inserting in lieu thereof
8 ice Act is amended by striking out "where appropriate”.
9 SEC. 4. Section 408 (a) of the Public Health Service 10 Act is amended by striking out “fifteen”.
SEC. 5. Section 409 (b) of the Public Health Service
12 Act is amended by striking out "and" before “$40,000,000" 13 and by inserting before the period at the end thereof a com
ma and the following: "$50,000,000 for the fiscal year end15 ing June 30, 1975, $65,000,000 for the fiscal year ending 16 June 30, 1976, and $85,000,000 for the fiscal year ending
(4) by adding after paragraph (8) the following
(9) to award grants for new construction as well as alterations and renovations for improvement of basic research laboratory facilities, including those related to
biohazard control, as deemed necessary for the national
SEC. 7. Section 4100 of the Public Health Service Act
9 is amended by striking out “and” before “$600,000,000" 10 and by inserting before the period at the end thereof a semi11 colon and the following: “$750,000,000 for the fiscal year 12 ending June 30, 1975; $830,000,000 for the fiscal year end13 ing June 30, 1976; and $985,000,000 for the fiscal year 14 ending June 30, 1977”.